您的位置: 首页 > 农业专利 > 详情页

NANOPARTICLE VACCINE ADJUVANT AND METHODS OF USE THEREOF
专利权人:
Massachusetts Institute of Technology;La Jolla Institute for Allergy and Immunology
发明人:
Darrell J. Irvine,Murillo Silva,Shane Crotty,Yu Kato
申请号:
US16510463
公开号:
US20200085756A1
申请日:
2019.07.12
申请国别(地区):
US
年份:
2020
代理人:
摘要:
Non-liposome, non-micelle particles formed of a lipid, an additional adjuvant such as a TLR4 agonist, a sterol, and a saponin are provided. The particles are porous, cage-like nanoparticles, also referred to as nanocages, and are typically between about 30 nm and about 60 nm. In some embodiments, the nanocages include or are administered in combination with an antigen. The particles can increase immune responses and are particularly useful as adjuvants in vaccine applications and related methods of treatment. Preferred lipids, additional adjuvants including TLR4 agonists, sterols, and saponins, methods of making the nanocages, and method of using them are also provided.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充